Cargando…

The risk factors of type 2 diabetes in hypertensive subjects

OBJECTIVE: Hypertension (HTN) and type 2 diabetes (T2DM) share common risk factors and usually co-occur. This study examined the relationship between HTN history and T2DM incidence in a cohort of Chinese hypertensive subjects. METHODS: We recruited 443 cases (T2DM and HTN) and 443 sex- and age-match...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yingqun, Ma, Jiner, Lu, Donghui, Fang, Yefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354076/
https://www.ncbi.nlm.nih.gov/pubmed/35937840
http://dx.doi.org/10.3389/fendo.2022.901614
_version_ 1784762984809103360
author Chen, Yingqun
Ma, Jiner
Lu, Donghui
Fang, Yefei
author_facet Chen, Yingqun
Ma, Jiner
Lu, Donghui
Fang, Yefei
author_sort Chen, Yingqun
collection PubMed
description OBJECTIVE: Hypertension (HTN) and type 2 diabetes (T2DM) share common risk factors and usually co-occur. This study examined the relationship between HTN history and T2DM incidence in a cohort of Chinese hypertensive subjects. METHODS: We recruited 443 cases (T2DM and HTN) and 443 sex- and age-matched controls (HTN). The history of peak systolic blood pressure (SBP) was divided into 140-159, 160-179, and ≥ 180 mmHg, and that of peak diastolic blood pressure (DBP) was divided into 90-99, 100-109, and ≥ 110 mmHg. Multiple binary logistic regression models were used to explore the association between controlled HTN status and T2DM. RESULTS: Creatinine concentrations were higher in the cases than in the controls (P < 0.05). The HTN duration was longer in the cases than in the controls (14.7 years vs. 13.2 years; P < 0.05). Significant differences were also found in the history of peak SBP and DBP between the cases and controls (both P < 0.05). Creatinine, HTN duration, and family history of T2DM were risk factors for T2DM in hypertensive subjects, with odds ratios (95% confidence intervals) of 1.013 (1.004-1.022), 1.025 (1.003-1.047), and 5.119 (3.266-8.026), respectively. Compared with the lowest level of peak DBP, the odds ratio for T2DM at the highest level of peak DBP was 1.757 (1.074-2.969). Subgroups analyses showed that the effect of the history of peak DBP on T2DM was significantly modified by sex (P-interaction = 0.037). CONCLUSION: The highest DBP and the longest HTN duration were both independently associated with T2DM in hypertensive subjects.
format Online
Article
Text
id pubmed-9354076
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93540762022-08-06 The risk factors of type 2 diabetes in hypertensive subjects Chen, Yingqun Ma, Jiner Lu, Donghui Fang, Yefei Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: Hypertension (HTN) and type 2 diabetes (T2DM) share common risk factors and usually co-occur. This study examined the relationship between HTN history and T2DM incidence in a cohort of Chinese hypertensive subjects. METHODS: We recruited 443 cases (T2DM and HTN) and 443 sex- and age-matched controls (HTN). The history of peak systolic blood pressure (SBP) was divided into 140-159, 160-179, and ≥ 180 mmHg, and that of peak diastolic blood pressure (DBP) was divided into 90-99, 100-109, and ≥ 110 mmHg. Multiple binary logistic regression models were used to explore the association between controlled HTN status and T2DM. RESULTS: Creatinine concentrations were higher in the cases than in the controls (P < 0.05). The HTN duration was longer in the cases than in the controls (14.7 years vs. 13.2 years; P < 0.05). Significant differences were also found in the history of peak SBP and DBP between the cases and controls (both P < 0.05). Creatinine, HTN duration, and family history of T2DM were risk factors for T2DM in hypertensive subjects, with odds ratios (95% confidence intervals) of 1.013 (1.004-1.022), 1.025 (1.003-1.047), and 5.119 (3.266-8.026), respectively. Compared with the lowest level of peak DBP, the odds ratio for T2DM at the highest level of peak DBP was 1.757 (1.074-2.969). Subgroups analyses showed that the effect of the history of peak DBP on T2DM was significantly modified by sex (P-interaction = 0.037). CONCLUSION: The highest DBP and the longest HTN duration were both independently associated with T2DM in hypertensive subjects. Frontiers Media S.A. 2022-07-22 /pmc/articles/PMC9354076/ /pubmed/35937840 http://dx.doi.org/10.3389/fendo.2022.901614 Text en Copyright © 2022 Chen, Ma, Lu and Fang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Chen, Yingqun
Ma, Jiner
Lu, Donghui
Fang, Yefei
The risk factors of type 2 diabetes in hypertensive subjects
title The risk factors of type 2 diabetes in hypertensive subjects
title_full The risk factors of type 2 diabetes in hypertensive subjects
title_fullStr The risk factors of type 2 diabetes in hypertensive subjects
title_full_unstemmed The risk factors of type 2 diabetes in hypertensive subjects
title_short The risk factors of type 2 diabetes in hypertensive subjects
title_sort risk factors of type 2 diabetes in hypertensive subjects
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354076/
https://www.ncbi.nlm.nih.gov/pubmed/35937840
http://dx.doi.org/10.3389/fendo.2022.901614
work_keys_str_mv AT chenyingqun theriskfactorsoftype2diabetesinhypertensivesubjects
AT majiner theriskfactorsoftype2diabetesinhypertensivesubjects
AT ludonghui theriskfactorsoftype2diabetesinhypertensivesubjects
AT fangyefei theriskfactorsoftype2diabetesinhypertensivesubjects
AT chenyingqun riskfactorsoftype2diabetesinhypertensivesubjects
AT majiner riskfactorsoftype2diabetesinhypertensivesubjects
AT ludonghui riskfactorsoftype2diabetesinhypertensivesubjects
AT fangyefei riskfactorsoftype2diabetesinhypertensivesubjects